Mitocin C MMC Purple solid. PROTECT FROM LIGHT. Antibiotic and carcinostatic agent. Inhibits DNA synthesis by cross-linking DNA at guanine and adenine residues; disrupts base pairing. Induces apoptosis in gastric cancer cells. Blocks the cell cycle at the G2 phase. Potency: ≥970 µg/mg. Biological activity: Potency: ≥ 970 mg/mg mitomycin C. Purity: ≥95% by HPLC. RTECS CN0700000, CAS 50-07-7. Merck Index: 14, 6215 Ref.: Kryt, F.A., et al. 1996. Blood 89, 938. Schwartz, G.K., et al. 1995. J. Natl. Cancer Inst. 87, 1394. Folnan, R.S., 1993. Oncology 50, 24. Tomasz, M., et al. 1987. Science 235, 1204. R: 28; S: 36/37-45-28 |